Cargando…
The pharmacodynamic effect of terlipressin versus high-dose octreotide in reducing hepatic venous pressure gradient: a randomized controlled trial
BACKGROUND: Vasoactive drugs can reduce portal venous pressure and control variceal bleeding. However, few studies have explored the hemodynamic effects of terlipressin and high-dose octreotide in such patients. Our purpose was to evaluate the hemodynamic changes and safety of using terlipressin and...
Autores principales: | Li, Bing, Chen, Jie, Zhang, Chun-Qing, Wang, Guang-Chuan, Hu, Jin-Hua, Luo, Jian-Jun, Zhang, Wen, Wei, Yi-Chao, Zeng, Xiao-Qing, Chen, Shi-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246168/ https://www.ncbi.nlm.nih.gov/pubmed/34268406 http://dx.doi.org/10.21037/atm-20-6774 |
Ejemplares similares
-
Rebound hypotension following terlipressin bolus infusion can be prevented by continuous low-dose infusion of terlipressin
por: Lange, M, et al.
Publicado: (2007) -
Terlipressin or Europressin?
por: Leone, Marc
Publicado: (2009) -
Correlation of pressure gradient in three hepatic veins with portal pressure gradient
por: Wang, Hao-Yu, et al.
Publicado: (2022) -
Measuring the hepatic venous pressure gradient in the upper digestive hemorrhages
por: Omer, S, et al.
Publicado: (2015) -
Terlipressin-induced hyponatraemia
por: Gray, R, et al.
Publicado: (2014)